‘IP is the driving force behind R&D.’
Saskia van Doorn
- Life Sciences
- European and Dutch Patent Attorney, European Patent Litigator
- Senior Associate
Saskia van Doorn started her career as a patent attorney in 2000 after having worked as an editor at Technisch Weekblad for four years. She studied biochemistry at the Radboud University Nijmegen (1991-1996).
News
UPC anti-anti-suit injunctions as interim measures: Munich Local Division in Huawei v Netgear (UPC_CFI_791/2024)
In its Order of 11 December 2024 in UPC_CFI_791/2024 (Munich Local Division), the Unified Patent Court (UPC) granted an ex parte anti-anti-suit/anti-enforcement injunction (AASI/AAEI) to prevent steps in US proceedings that were said to obstruct UPC patent enforcement. The decision is noteworthy for its articulation of the UPC’s jurisdictional basis and the procedural framework for […]Continue reading
R 0016/23: the Enlarged Board confirms the mandatory nature of oral proceedings upon request under Article 116(1) EPC
In R 0016/23 (Enlarged Board of Appeal, 21 November 2025), the Enlarged Board set aside a Legal Board of Appeal decision which had dismissed an appeal without holding requested oral proceedings. The decision is a clear statement that efficiency and “timely legal certainty” cannot, in themselves, justify restricting the scope of Article 116(1) EPC when […]Continue reading
Medical-device infringement and “standard use”: LD Munich on lege artis use and conditional revocation counterclaims (UPC_CFI_628/2024)
In its decision on the merits in UPC_CFI_628/2024 (with the related revocation counterclaim UPC_CFI_125/2025), the Munich Local Division of the Unified Patent Court (UPC) addressed two practically relevant issues:Continue reading